• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON ENDO-SURGERY, LLC. ILS 33MM, CURVED; STAPLE, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON ENDO-SURGERY, LLC. ILS 33MM, CURVED; STAPLE, IMPLANTABLE Back to Search Results
Model Number ECS33A
Medical Device Problem Code Failure to Fire (2610)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/19/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).Batch # unk the lot/batch was not provided; therefore, the manufacturing record evaluation could not be performed.
 
Event or Problem Description
It was reported that during a sigmoid resection procedure that the device misfired and only deployed a half circle.Anastomosis was completed using silk suture.There were no adverse consequences for the patient.
 
Additional Manufacturer Narrative
(b)(4).Date sent: 07/09/2021.D4: batch # u5e40a.H6: component code = mechanical (g04).Device analysis: the product was returned to ethicon endo-surgery for evaluation.Visual inspection and functional testing were conducted on the returned device.Visual analysis of the returned sample determined that the ecs33a device arrived with no apparent damage.The breakaway washer uncut and indented and there was no staples present.The device was reloaded with staples and tested for functionality with a test washer; the device formed all the staples, as well as completely cut the test media and the breakaway washer without incident.The staple line was complete, and the staples meet the staple form release criteria.The event reported was confirmed and it is related an improper use of the device.The condition of the washer indicates that the device had not been fired through a full firing stroke or possibly that the orange indicator was not fully into the safe green firing range.Before firing the device the orange indicator should be fully within the green range of the gap setting scale and the safety should not be released prior to firing.Also, if the firing sequence is not fully completed (the firing handle reaches its stopping point, and the firing trigger is parallel to the instrument handle) staples could be partially deployed without cutting the washer.Please reference the instruction for use for more information.As part of ethicon endo surgery¿s quality process, all devices are manufactured, inspected, and released to approved specifications.A manufacturing record evaluation was performed for the finished device batch number, and no non-conformances were identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ILS 33MM, CURVED
Common Device Name
STAPLE, IMPLANTABLE
Manufacturer (Section D)
ETHICON ENDO-SURGERY, LLC.
475 calle c
guaynabo 00969
MDR Report Key11991277
Report Number3005075853-2021-03284
Device Sequence Number805112
Product Code GDW
UDI-Device Identifier10705036012412
UDI-Public10705036012412
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K940967
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 05/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/05/2025
Device Model NumberECS33A
Device Catalogue NumberECS33A
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer06/11/2021
Initial Date Received by Manufacturer 05/20/2021
Supplement Date Received by Manufacturer07/02/2021
Initial Report FDA Received Date06/14/2021
Supplement Report FDA Received Date07/09/2021
Patient Sequence Number1
-
-